Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

CLARIGET OD - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/CLARIGET OD

Approved

STANDARD

CLARIGET OD

Getz Pharma (Private) Limited🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: ef07ab3a1ad684eb
Company: Getz Pharma (Private) Limited
Type: Standard

Approval Details

Approval Id: ef07ab3a1ad684eb
Drug Approval Philippines Name: CLARIGET OD
Product Name: CLARIGET OD
Registration Number: DR-XY37281
Brand Name: CLARIGET OD
Generic Name: Clarithromycin
Dosage Form: Extended Release Tablet
Dosage Strength: 500mg
Manufacturer: Getz Pharma (Private) Limited
Importer: Getz Pharma (Phils.), Inc.
Issuance Date: 27 September 2024
Expiry Date: 29 December 2029
Pharmacologic Category: Antibacterial (Macrolide)
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

ef07ab3a1ad684eb

Type

Standard

Back to Philippines FDA Approvals